{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:18:54Z","timestamp":1783448334688,"version":"3.55.0"},"reference-count":17,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":134,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate differences in clinical presentation, diagnostic and therapeutic modalities, and outcomes in two cohorts of patients with sporadic medullary thyroid carcinoma (MTC) from reference centres in Italy and the Netherlands. The two centres have different diagnostic approaches, including the use of routine calcitonin (CT) measurement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 165 patients (106 Italian and 59 Dutch) were retrospectively included. The cohorts were compared overall and according to diagnostic modality. Logistic regression and multivariable Cox proportional hazards models were used, as appropriate, to assess progression-free survival (PFS), disease-specific survival (DSS) and associated risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The Dutch cohort presented with more advanced disease, as per higher TNM, AJCC staging, and significantly higher CT both preoperative and at last visit (P &amp;lt; 0.001). Dutch patients received more frequently second operations, radiotherapy, and systemic treatments. PFS and 10-year DSS were significantly lower in the Dutch cohort (P &amp;lt; 0.001 and P 0.01). Tumour size, nodal involvement, presence of distant metastases at diagnosis and progression during the follow-up were independent strong predictors of shorter PFS and DSS. Patients diagnosed via routine CT measurement showed a less aggressive presentation and more favourable outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We compared for the first time two MTC cohorts from countries with different diagnostic and therapeutic approaches. Our data contribute to highlighting an association between routine CT measurement and MTC presentation and outcome, while suggesting that caution should be exercised when interpreting the differences among countries in MTC prevalence and clinical features.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-25-0381","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:13:21Z","timestamp":1770725601000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":0,"title":["Clinical presentation and outcomes of medullary thyroid cancer in two European countries: impact of diagnostic strategies"],"prefix":"10.1530","volume":"15","author":[{"given":"Daniele","family":"Ceruti","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han J","family":"Bonenkamp","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Colombo","sequence":"additional","affiliation":[{"name":"3"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gotthardt","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"De Leo","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonius E","family":"van Herwaarden","sequence":"additional","affiliation":[{"name":"7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petronella B","family":"Ottevanger","sequence":"additional","affiliation":[{"name":"8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana T","family":"Netea-Maier","sequence":"additional","affiliation":[{"name":"9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-0982","authenticated-orcid":true,"given":"Laura","family":"Fugazzola","sequence":"additional","affiliation":[{"name":"6"},{"name":"10"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2026070713595701600_bib1","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.22244","article-title":"Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1,252 cases","volume":"107","author":"Roman","year":"2006","journal-title":"Cancer"},{"key":"2026070713595701600_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/jc.2006-1590","article-title":"Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5,817 consecutive patients with thyroid nodules","volume":"92","author":"Costante","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713595701600_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/jc.2003-030550","article-title":"Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders","volume":"89","author":"Elisei","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713595701600_bib4","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0067","article-title":"2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management","volume":"12","author":"Durante","year":"2023","journal-title":"Eur Thyroid J"},{"key":"2026070713595701600_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"2026070713595701600_bib6","article-title":"Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules","volume":"3","author":"Verbeek","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2026070713595701600_bib7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3906\/c","article-title":"Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer","volume":"51","author":"Kartal Baykan","year":"2021","journal-title":"Turk J Med Sci"},{"key":"2026070713595701600_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40618-020-01356-9","article-title":"Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment","volume":"44","author":"Fugazzola","year":"2021","journal-title":"J Endocrinol Investig"},{"key":"2026070713595701600_bib9","article-title":"Richtlijn schildkliercarcinoom inclusief diagnostiek van de nodus [guideline thyroid cancer including diagnostics of the nodule]","volume":"159","author":"Links","year":"2015","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2026070713595701600_bib10","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2026070713595701600_bib11","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"2026070713595701600_bib12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"2026070713595701600_bib13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-12-0943","article-title":"Radioactive iodine in the treatment of medullary thyroid carcinoma: a controlled multicentre study","volume":"168","author":"Meijer","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2026070713595701600_bib14","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/cancers17060950","article-title":"Body mass index and sporadic medullary thyroid cancer: insights from a large series","volume":"17","author":"Prete","year":"2025","journal-title":"Cancers"},{"key":"2026070713595701600_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/thy.2024.0433","article-title":"Trends in the incidence, organization of care, and surgical treatment of medullary thyroid cancer: a population-based study","volume":"35","author":"Jager","year":"2025","journal-title":"Thyroid"},{"key":"2026070713595701600_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-21-0313","article-title":"Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma","volume":"185","author":"Matrone","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2026070713595701600_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/cen.12563","article-title":"Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis","volume":"82","author":"Trimboli","year":"2015","journal-title":"Clin Endocrinol"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/15\/1\/ETJ-25-0381.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/15\/1\/ETJ-25-0381.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0381\/508630\/etj-25-0381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0381\/508630\/etj-25-0381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:00:03Z","timestamp":1783447203000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/1\/ETJ250381\/75606\/Clinical-presentation-and-outcomes-of-medullary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0381","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"article-number":"ETJ250381"}}